- Home
- NEO vs CRTO Comparison
NEO vs CRTO Comparison
Compare NEO & CRTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEO
- CRTO
- Stock Information
- Founded
- NEO 2001
- CRTO 2005
- Country
- NEO United States
- CRTO France
- Employees
- NEO N/A
- CRTO N/A
- Industry
- NEO Precision Instruments
- CRTO Advertising
- Sector
- NEO Health Care
- CRTO Consumer Discretionary
- Exchange
- NEO Nasdaq
- CRTO Nasdaq
- Market Cap
- NEO 1.2B
- CRTO 1.1B
- IPO Year
- NEO 1999
- CRTO 2013
- Fundamental
- Price
- NEO $10.21
- CRTO $21.99
- Analyst Decision
- NEO Buy
- CRTO Buy
- Analyst Count
- NEO 10
- CRTO 9
- Target Price
- NEO $12.56
- CRTO $39.11
- AVG Volume (30 Days)
- NEO 5.6M
- CRTO 435.3K
- Earning Date
- NEO 10-28-2025
- CRTO 10-29-2025
- Dividend Yield
- NEO N/A
- CRTO N/A
- EPS Growth
- NEO N/A
- CRTO 83.79
- EPS
- NEO N/A
- CRTO 3.00
- Revenue
- NEO $709,162,000.00
- CRTO $1,956,800,000.00
- Revenue This Year
- NEO $10.40
- CRTO N/A
- Revenue Next Year
- NEO $10.11
- CRTO $1.84
- P/E Ratio
- NEO N/A
- CRTO $7.40
- Revenue Growth
- NEO 10.10
- CRTO 0.53
- 52 Week Low
- NEO $4.72
- CRTO $19.50
- 52 Week High
- NEO $19.12
- CRTO $47.27
- Technical
- Relative Strength Index (RSI)
- NEO 60.50
- CRTO 57.68
- Support Level
- NEO $9.83
- CRTO $20.33
- Resistance Level
- NEO $11.41
- CRTO $22.70
- Average True Range (ATR)
- NEO 0.48
- CRTO 0.67
- MACD
- NEO -0.05
- CRTO 0.27
- Stochastic Oscillator
- NEO 48.03
- CRTO 77.81
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
About CRTO Criteo S.A.
Criteo SA is an ad-tech company in the digital advertising market. Its technology, allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. It has two reportable segments: Retail Media and Performance Media. The firm also provides technology allowing retailers to effectively manage their ad inventories and improve yield optimization.